Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders

J Spaas, L Van Veggel, M Schepers, A Tiane… - Cellular and Molecular …, 2021 - Springer
Oligodendrocyte precursor cells (OPCs) account for 5% of the resident parenchymal central
nervous system glial cells. OPCs are not only a back-up for the loss of oligodendrocytes that …

Endo-lysosomal dysregulations and late-onset Alzheimer's disease: impact of genetic risk factors

ZP Van Acker, M Bretou, W Annaert - Molecular neurodegeneration, 2019 - Springer
Increasing evidence supports that cellular dysregulations in the degradative routes
contribute to the initiation and progression of neurodegenerative diseases, including …

Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level

ECB Johnson, EK Carter, EB Dammer, DM Duong… - Nature …, 2022 - nature.com
The biological processes that are disrupted in the Alzheimer's disease (AD) brain remain
incompletely understood. In this study, we analyzed the proteomes of more than 1,000 brain …

Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and …

ECB Johnson, EB Dammer, DM Duong, L Ping… - Nature medicine, 2020 - nature.com
Our understanding of Alzheimer's disease (AD) pathophysiology remains incomplete. Here
we used quantitative mass spectrometry and coexpression network analysis to conduct the …

Machine learning identifies candidates for drug repurposing in Alzheimer's disease

S Rodriguez, C Hug, P Todorov, N Moret… - Nature …, 2021 - nature.com
Clinical trials of novel therapeutics for Alzheimer's Disease (AD) have consumed a large
amount of time and resources with largely negative results. Repurposing drugs already …

Molecular subtyping of Alzheimer's disease using RNA sequencing data reveals novel mechanisms and targets

RA Neff, M Wang, S Vatansever, L Guo, C Ming… - Science …, 2021 - science.org
Alzheimer's disease (AD), the most common form of dementia, is recognized as a
heterogeneous disease with diverse pathophysiologic mechanisms. In this study, we …

[HTML][HTML] Meta-analysis of the Alzheimer's disease human brain transcriptome and functional dissection in mouse models

YW Wan, R Al-Ouran, CG Mangleburg, TM Perumal… - Cell reports, 2020 - cell.com
We present a consensus atlas of the human brain transcriptome in Alzheimer's disease
(AD), based on meta-analysis of differential gene expression in 2,114 postmortem samples …

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease

L Higginbotham, L Ping, EB Dammer, DM Duong… - Science …, 2020 - science.org
Alzheimer's disease (AD) lacks protein biomarkers reflective of its diverse underlying
pathophysiology, hindering diagnostic and therapeutic advancements. Here, we used …

Human neural cell type‐specific extracellular vesicle proteome defines disease‐related molecules associated with activated astrocytes in Alzheimer's disease brain

Y You, S Muraoka, MP Jedrychowski… - Journal of …, 2022 - Wiley Online Library
In neurodegenerative diseases, extracellular vesicles (EVs) transfer pathogenic molecules
and are consequently involved in disease progression. We have investigated the proteomic …

Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer's disease

X Zhang, R Wang, D Hu, X Sun, H Fujioka… - Science …, 2020 - science.org
Myelin degeneration and white matter loss resulting from oligodendrocyte (OL) death are
early events in Alzheimer's disease (AD) that lead to cognitive deficits; however, the …